{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:17:41Z","timestamp":1790399861990,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007657","name":"University of Ljubljana","doi-asserted-by":"publisher","award":["SN-ZRD\/22\\u201327\/0510"],"award-info":[{"award-number":["SN-ZRD\/22\\u201327\/0510"]}],"id":[{"id":"10.13039\/501100007657","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001671","name":"European Synchrotron Radiation Facility","doi-asserted-by":"publisher","award":["A07\\u201319"],"award-info":[{"award-number":["A07\\u201319"]}],"id":[{"id":"10.13039\/501100001671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001671","name":"European Synchrotron Radiation Facility","doi-asserted-by":"publisher","award":["BM07-FIP2"],"award-info":[{"award-number":["BM07-FIP2"]}],"id":[{"id":"10.13039\/501100001671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001671","name":"European Synchrotron Radiation Facility","doi-asserted-by":"publisher","award":["A07-1-19"],"award-info":[{"award-number":["A07-1-19"]}],"id":[{"id":"10.13039\/501100001671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P1-0208"],"award-info":[{"award-number":["P1-0208"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["BI-FR\/23-24-PROTEUS-002"],"award-info":[{"award-number":["BI-FR\/23-24-PROTEUS-002"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P4-0127"],"award-info":[{"award-number":["P4-0127"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["N1-0277"],"award-info":[{"award-number":["N1-0277"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006021","name":"Direction G\u00e9n\u00e9rale de l\u2019Armement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016398","name":"Minist\u00e8re des Arm\u00e9es","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020913","name":"Service de Sant\u00e9 des Arm\u00e9es","doi-asserted-by":"publisher","award":["NBC-5-C-2316"],"award-info":[{"award-number":["NBC-5-C-2316"]}],"id":[{"id":"10.13039\/100020913","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cbi.2025.111670","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T06:44:17Z","timestamp":1753253057000},"page":"111670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Chiral switch of a butyrylcholinesterase inhibitor for the treatment of Alzheimer's disease"],"prefix":"10.1016","volume":"420","author":[{"given":"Urban","family":"Ko\u0161ak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damijan","family":"Knez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svit Ferjan\u010di\u010d","family":"Benetik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Mastnak","family":"Sokolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Pi\u0161lar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selena","family":"Horvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jure","family":"Stojan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Igert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Nachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Brazzolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haopeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-3083","authenticated-orcid":false,"given":"Stanislav","family":"Gobec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2025.111670_bib1","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1021\/jm501195e","article-title":"Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor","volume":"57","author":"Brus","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111670_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cbi.2025.111670_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1185\/03007990152673800","article-title":"A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase","volume":"17","author":"Greig","year":"2001","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.cbi.2025.111670_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1041610203008676","article-title":"Butyrylcholinesterase: an important new target in Alzheimer's disease therapy","volume":"14","author":"Greig","year":"2002","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.cbi.2025.111670_bib5","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2174\/1567205013666160404120542","article-title":"Butyrylcholinesterase as a diagnostic and therapeutic target for Alzheimer's disease","volume":"13","author":"Darvesh","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.cbi.2025.111670_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/srep39495","article-title":"Development of an in-vivo active reversible butyrylcholinesterase inhibitor","volume":"6","author":"Ko\u0161ak","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2025.111670_bib7","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM198611133152001","article-title":"A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type","volume":"315","author":"Summers","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2025.111670_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1017\/S1041610201007876","article-title":"Butyrylcholinesterase and cognitive function","volume":"13","author":"Darvesh","year":"2001","journal-title":"Int. Psychogeriatr."},{"issue":"47","key":"10.1016\/j.cbi.2025.111670_bib9","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer \u03b2-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cbi.2025.111670_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acs.jmedchem.7b01086","article-title":"S. The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in vivo activity","volume":"61","author":"Ko\u0161ak","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111670_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112766","article-title":"Structure-activity relationship study of tryptophan-based butyrylcholinesterase inhibitors","volume":"208","author":"Meden","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111670_bib12","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1021\/jacs.1c13492","article-title":"Photoswitchable pseudoirreversible butyrylcholinesterase inhibitors allow optical control of inhibition in vitro and enable restoration of Cognition in an Alzheimer's disease mouse model upon irradiation","volume":"144","author":"Scheiner","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cbi.2025.111670_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114510","article-title":"A highly effective and stable butyrylcholinesterase inhibitor with multi-faceted neuroprotection and cognition improvement","volume":"239","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111670_bib14","doi-asserted-by":"crossref","first-page":"11365","DOI":"10.1021\/acs.jmedchem.2c00944","article-title":"N-benzyl benzamide derivatives as selective sub-nanomolar butyrylcholinesterase inhibitors for possible treatment in advanced Alzheimer's disease","volume":"65","author":"Du","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111670_bib15","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ejmech.2018.07.033","article-title":"Multi-target-directed ligands for treating Alzheimer's disease: butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities","volume":"156","author":"Knez","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111670_bib16","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1021\/jm060682m","article-title":"Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterase with dirigible selectivity towards butyrylcholinesterase","volume":"49","author":"Decker","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111670_bib17","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1021\/jm8002747","article-title":"Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, \u03b2 amyloid aggregation, and A\u03b2 neurotoxicity","volume":"51","author":"Rizzo","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111670_bib18","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1021\/jm8002075","article-title":"Carbamates with differential mechanism of inhibition toward acetycholinesterase and butyrycholinesterase","volume":"51","author":"Darvesh","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111670_bib19","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1021\/jm9014845","article-title":"Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor","volume":"53","author":"Carolan","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111670_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1021\/acs.jmedchem.5b01119","article-title":"Novel tacrinebenzofuran hybrids as potent multitarget-directed ligands for the treatment of Alzheimer's disease: design, synthesis, biological evaluation, and X-ray crystallography","volume":"59","author":"Zha","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111670_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97404-2","article-title":"Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor","volume":"11","author":"Zako\u0161ek Pipan","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2025.111670_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2005.11.021","article-title":"Cognitive disturbances in old dogs suffering from the canine counterpart of Alzheimer's disease","volume":"1069","author":"Rofina","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2025.111670_bib23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fnins.2019.00604","article-title":"Canine cognitive dysfunction and Alzheimer's disease \u2013 two facets of the same disease?","volume":"13","author":"Prpar Mihevc","year":"2019","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.cbi.2025.111670_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.phrs.2003.11.017","article-title":"Cholinesterase inhibitors: new roles and therapeutic alternatives","volume":"50","author":"Giacobini","year":"2004","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.cbi.2025.111670_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2125.1999.00026.x","article-title":"Acetylcholinesterase inhibitors in Alzheimer's disease","volume":"48","author":"McGleenon","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.cbi.2025.111670_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1567205054367838","article-title":"Cholinesterases: roles in the brain during health and disease","volume":"2","author":"Ballard","year":"2005","journal-title":"Curr. Alzheimer Res."},{"issue":"9209","key":"10.1016\/j.cbi.2025.111670_bib27","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(00)02047-X","article-title":"Chiral switches","volume":"335","author":"Tucker","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2025.111670_bib28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrd915","article-title":"Putting chirality to work: the strategy of the chiral switches","volume":"1","author":"Agranat","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.cbi.2025.111670_bib29","first-page":"e90","article-title":"Assessing the chiral switch: approval and use of single-enantiomer drugs, 2001 to 2011","volume":"20","author":"Gellad","year":"2014","journal-title":"Am. J. Manag. Care"},{"issue":"2","key":"10.1016\/j.cbi.2025.111670_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/ph15020240","article-title":"Chiral switch: between therapeutical benefit and marketing strategy","volume":"15","author":"Hancu","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cbi.2025.111670_bib31","first-page":"211","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies, Sig. Transduct","volume":"9","author":"Zhang","year":"2024","journal-title":"Target Ther."},{"key":"10.1016\/j.cbi.2025.111670_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111670_bib33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bmc.2016.11.032","article-title":"N-propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: potential multifunctional anti-alzheimer\u2019s agents","volume":"25","author":"Ko\u0161ak","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111670_bib34","author":"Ko\u0161ak"},{"key":"10.1016\/j.cbi.2025.111670_bib35","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1021\/acs.chas.2c00035","article-title":"Lessons learned\u2013lithium aluminum hydride fires","volume":"29","author":"Merlic","year":"2022","journal-title":"ACS Chem. Health Safe"},{"key":"10.1016\/j.cbi.2025.111670_bib36","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nrd2075","article-title":"Drug discovery in dementia: the role of rodent models","volume":"5","author":"Van Dam","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cbi.2025.111670_bib37","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1046\/j.1365-2362.1998.00393.x","article-title":"Scopolamine model of dementia: electroencephalogram findings and cognitive performance","volume":"28","author":"Ebert","year":"1998","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.cbi.2025.111670_bib38","doi-asserted-by":"crossref","first-page":"9748","DOI":"10.1038\/srep09748","article-title":"Scopolamine effects on functional brain connectivity: a pharmacological model of Alzheimer's disease","volume":"5","author":"Bajo","year":"2015","journal-title":"Sci. Rep."},{"issue":"34","key":"10.1016\/j.cbi.2025.111670_bib39","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","article-title":"A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies","volume":"34","author":"Klinkenberg","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.cbi.2025.111670_bib40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jalz.2005.09.004","article-title":"Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor","volume":"1","author":"Snyder","year":"2005","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.cbi.2025.111670_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.euroneuro.2004.11.006","article-title":"Rats with scopolamine- or MK-801-induced spatial discrimination deficits in the cone field task: animal models for impaired spatial orientation performance","volume":"15","author":"Bouger","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.cbi.2025.111670_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2004.05.010","article-title":"Effects of the cholinesterase inhibitors donepezil and metrifonate on scopolamine-induced impairments in the spatial cone field orientation task in rats","volume":"156","author":"van der Staay","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cbi.2025.111670_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-4328(98)00052-7","article-title":"Sensitivity to cholinergic drug treatments of aged rats with variable degrees of spatial memory impairment","volume":"98","author":"Stemmelin","year":"1999","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cbi.2025.111670_bib44","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00213-014-3813-x","article-title":"Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey","volume":"232","author":"Vardigan","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.cbi.2025.111670_bib45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bbr.2008.10.029","article-title":"Evaluation of spatial memory of C57BL\/6J and CD1 mice in the Barnes maze, the multiple T-maze and in the Morris water maze","volume":"198","author":"Patil","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cbi.2025.111670_bib46","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bcp.2014.01.011","article-title":"Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines","volume":"88","author":"Puzzo","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111670_bib47","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cbi.2025.111670_bib48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","article-title":"The novel object recognition memory: neurobiology, test procedure, and its modifications","volume":"13","author":"Antunes","year":"2012","journal-title":"Cogn. Process."},{"key":"10.1016\/j.cbi.2025.111670_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2014.08.002","article-title":"Assessing rodent hippocampal involvement in the novel object recognition task. A review","volume":"285","author":"Cohen","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cbi.2025.111670_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30030-7","article-title":"The discrimination ratio derived from novel object recognition tasks as a measure of recognition memory sensitivity, not bias","volume":"8","author":"Sivakumaran","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2025.111670_bib51","first-page":"105","article-title":"The Y-maze for assessment of spatial working and reference memory in mice","volume":"1916","author":"Kraeuter","year":"2019"},{"key":"10.1016\/j.cbi.2025.111670_bib52","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2019.01.012","article-title":"A window into the brain: tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders","volume":"148","author":"Samal","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cbi.2025.111670_bib53","article-title":"A quantitative analysis of spontaneous alternation behaviors on a Y-maze reveals adverse effects of acute social isolation on spatial working memory","volume":"13","author":"Kim","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2025.111670_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yrtph.2013.04.003","article-title":"A global pharmaceutical company initiative: an evidence-based approach to define the upper limit of body weight loss in short term toxicity studies","volume":"67","author":"Chapman","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111670_bib55","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.0014-2956.2001.02692.x","article-title":"Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization","volume":"269","author":"Nachon","year":"2002","journal-title":"Eur. J. Biochem."},{"issue":"16","key":"10.1016\/j.cbi.2025.111670_bib56","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/j.1742-4658.2012.08672.x","article-title":"Human butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure","volume":"279","author":"Brazzolotto","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.cbi.2025.111670_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.cbi.2025.111670_bib58","first-page":"1204","article-title":"How good are my data and what is the resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.cbi.2025.111670_bib59","first-page":"213","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.cbi.2025.111670_bib60","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1107\/S0907444909029436","article-title":"Electronic ligand builder and optimization workbench (eLBOW): a tool for ligand coordinate and restraint generation","volume":"65","author":"Moriarty","year":"2009","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.cbi.2025.111670_bib61","first-page":"486","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972500300X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972500300X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:15:33Z","timestamp":1777400133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000927972500300X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":61,"alternative-id":["S000927972500300X"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111670","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chiral switch of a butyrylcholinesterase inhibitor for the treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111670"}}